In a 74-year-old patient with severe chronic obstructive pulmonary disease (COPD) on bilevel positive airway pressure (BiPAP) and comorbid anxiety/depression, should quetiapine (Seroquel) 25 mg three times daily be continued or discontinued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Discontinue Quetiapine Immediately

In a 74-year-old patient with severe COPD on BiPAP, quetiapine 25 mg TID should be discontinued due to significant risk of acute respiratory failure and respiratory depression, particularly given the documented case of respiratory failure after a single 50 mg dose in an elderly COPD patient.

Critical Safety Concerns

The FDA label explicitly warns that quetiapine causes somnolence, sedation, and CNS depression 1. More critically, a published case report documents acute respiratory failure requiring mechanical ventilation after a single 50 mg dose in a 92-year-old woman with COPD 2. Your patient is receiving 75 mg daily (25 mg TID), and is already on BiPAP for severe COPD with respiratory compromise—this represents an unacceptable risk profile.

Key Risk Factors Present:

  • Advanced age (74 years) - elderly patients have 30-50% reduced clearance of quetiapine 1
  • Severe underlying pulmonary disease - the primary risk factor for quetiapine-induced respiratory failure 2
  • Already requiring BiPAP - indicates baseline respiratory insufficiency
  • Orthostatic hypotension risk - quetiapine causes this in 4-7% of adults, which can lead to falls and injuries 1

Alternative Management Strategy

For anxiety and depression in severe COPD patients:

  1. First-line non-pharmacologic interventions:

    • Pulmonary rehabilitation (proven effective for both respiratory function AND psychiatric symptoms) 3, 4
    • Cognitive behavioral therapy (small but consistent benefits) 4, 5
    • BiPAP optimization (your patient is already receiving this—it improves anxiety/depression by improving oxygenation and reducing work of breathing) 3

  2. If pharmacotherapy is absolutely necessary:

    • Consider SSRIs (sertraline, escitalopram) with careful monitoring—these have better safety profiles in COPD than sedating antipsychotics 6, 7
    • Start at lowest possible doses given age and comorbidities
    • Avoid all sedating medications in patients with respiratory compromise

  3. Address reversible contributors:

    • Optimize COPD management per GOLD guidelines (bronchodilators, inhaled corticosteroids if indicated) 8
    • Ensure adequate oxygenation
    • Screen for and treat hypercapnia (which itself causes anxiety and altered mental status)

Common Pitfall to Avoid

Do not assume that because quetiapine is "atypical" and commonly used in the elderly that it is safe in severe COPD. The case report demonstrates that even low doses can cause life-threatening respiratory depression in this population 2. The Naranjo probability scale rated the causality as "probable" in that case.

The COPD guidelines emphasize optimizing respiratory management and pulmonary rehabilitation 8, 9, while psychiatric literature consistently shows that treating the underlying COPD improves psychiatric symptoms 3, 4, 5. This patient needs better COPD management and non-pharmacologic psychiatric interventions, not a sedating antipsychotic that directly threatens their already compromised respiratory status.

References

7
Research

Management of anxiety and depression in patients with COPD.

Expert review of respiratory medicine, 2008

Related Questions

What medication options are appropriate for managing severe anxiety and depression in a 74‑year‑old patient with chronic obstructive pulmonary disease (COPD) who is using bilevel positive airway pressure (BiPAP)?
For a 74‑year‑old patient with COPD on BiPAP who has severe anxiety and depression and is currently taking alprazolam 0.25 mg three times daily as needed, hydroxyzine 25 mg three times daily as needed, sertraline 25 mg three times daily, and mirtazapine 15 mg daily, how should the medication regimen be simplified and optimized?
Can benzodiazepines alone cause respiratory depression in an elderly female patient with Chronic Obstructive Pulmonary Disease (COPD) and anxiety, particularly with Xanax (alprazolam)?
Can Seroquel (quetiapine) cause respiratory depression?
In a 77‑year‑old patient on quetiapine 100 mg in the morning and 200 mg at bedtime, with a rib fracture, receiving oxygen and at high risk for respiratory depression and falls, can the dose be abruptly reduced to 50 mg twice daily?
For a 74‑year‑old patient with COPD on BiPAP who has severe anxiety and depression and is currently taking alprazolam 0.25 mg three times daily as needed, hydroxyzine 25 mg three times daily as needed, sertraline 25 mg three times daily, and mirtazapine 15 mg daily, how should the medication regimen be simplified and optimized?
Can you give me information in Portuguese about Pan‑Chung‑Bellen syndrome?
What is squamous metaplasia?
How long should a patient with a history of pulmonary embolism that occurred more than six months ago, without atrial fibrillation or prior cerebrovascular accident, be anticoagulated with warfarin?
What is the clinical significance and recommended management for a pediatric patient with a FRYL c.3170-1G>A splice-site variant identified on exome sequencing?
In a 58-year-old male with diabetes mellitus and angina and an LDL cholesterol of 101 mg/dL, and a 42-year-old female with no comorbidities and an LDL cholesterol of 168 mg/dL, should atorvastatin be prescribed for both patients, and what initial dose and LDL‑C target should be used for each?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.